Alfuxyle T 2.5 Tablet contains Alfuzosin 10mg + Tadalafil 2.5mg, a dual-action therapy for effective management of BPH and erectile dysfunction. Alfuzosin relaxes prostate and bladder muscles to improve urinary flow, while Tadalafil enhances blood circulation to support erectile function.
This combination is clinically preferred by urologists due to its synergistic action, safety profile, and patient tolerability, providing reliable symptom relief for both urinary and sexual health issues. Patients experience better quality of life, improved urinary comfort, and enhanced sexual performance.
For franchise partners, Alfuxyle T 2.5 Tablet is a high-demand product in the urology care segment, ensuring strong market acceptance and repeat prescriptions. Its dual-therapy approach makes it a profitable addition to specialty portfolios, boosting sales and strengthening business growth.
With increasing prevalence of BPH and erectile dysfunction, Alfuxyle T 2.5 Tablet offers sustainable sales opportunities, helping partners establish a strong presence in the urology care segment.